Granules India's Stock Hits New High, Receives 'Buy' Call from MarketsMOJO

Granules India, a leading pharmaceutical company in the midcap sector, has been making headlines with its recent stock performance. On February 16, 2024, the company's stock gained 5.02%, closing at Rs. 458.45, which is also its new 52-week and all-time high. This impressive performance has caught the attention of MarketsMOJO, who have given a 'Buy' call for the stock. The stock has been on a winning streak for the past 5 days, with a consecutive gain of 9%. This has resulted in the stock outperforming the sector by 3.58% in today's trading session. The intraday high of Rs. 458.45, which is a 5.15% increase, further solidifies the company's strong performance. Granules India's stock is also trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend for the company. In comparison to the Sensex, the stock has outperformed with a 1-day performance of 5.06% versus the Sensex's 0.58% and a 1-month performance of 7.00% versus the Sensex's -0.90%. With such impressive numbers, it's no surprise that MarketsMOJO has given a 'Buy' call for Granules India's stock. The company's consistent growth and strong performance in the pharmaceutical industry make it a promising investment opportunity for midcap investors.